Prognostic value of immunohistochemically detected p53 expression in vulvar carcinoma
- 15 November 1995
- Vol. 76 (10) , 1786-1789
- https://doi.org/10.1002/1097-0142(19951115)76:10<1786::aid-cncr2820761016>3.0.co;2-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Mutant p53 in Patients with Invasive Cervical Cancer Stages IB to IIBGynecologic Oncology, 1995
- Identification of p53 mutations by means of single strand conformation polymorphism analysis in gynaecological tumours: Comparison with the results of immunohistochemistryEuropean Journal Of Cancer, 1994
- P53 protein expression and prognosis in squamous cell carcinoma of the esophagusCancer, 1994
- Expression of EGFR, HER-2/neu, P53, and PCNA in Endometrioid, Serous Papillary, and Clear Cell Endometrial AdenocarcinomasGynecologic Oncology, 1994
- Overexpression of p53 Is Not a Feature of Benign and Early-Stage Borderline Epithelial Ovarian TumorsGynecologic Oncology, 1994
- p53 mutations in human bladder cancer: Genotypic versus phenotypic patternsInternational Journal of Cancer, 1994
- Papillomavirus, p53 alteration and primary carcinoma of the vulvaEuropean Journal Of Cancer, 1993
- Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinomaThe Lancet, 1992
- The p53 tumour suppressor geneNature, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958